Cogent Biosciences share price logo

Cogent Biosciences

NASDAQ: COGT

Mid Cap

$35.00

+0.33

(+0.95%)

as on

Cogent Biosciences Stock Performance

as on September 1, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $34.12
    $35.20
    downward going graph

    2.51%

    Downside

    0.57%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $11.60
    $43.73
    downward going graph

    66.86%

    Downside

    24.94%

    Upside

    downward going graph

Cogent Biosciences share price movements today

Previous Close
$34.67
Open
$34.82
Volume
1.2M
Market Cap
$6.0B
Day's Low - High
$34.12 - $35.20
52 Week Low - High
$11.60 - $43.73

Cogent Biosciences Historical Returns

1 Month Return
-10.94 %
3 Month Return
-0.83 %
1 Year Return
+ 187 %
3 Year Return
+ 183.95 %
5 Year Return
+ 318.72 %

Cogent Biosciences Stock Fundamentals & Key Indicators

Check Cogent Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.0B

EPS (TTM)

-2.31

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-16.15

Industry PE ratio

-13.495176470588236

PEG Ratio

-1.780266684916326

EBITDA

-372.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-72.57%

Cogent Biosciences Stock Valuation

Track how Cogent Biosciences P/E has moved over time to understand its valuation trends.

Cogent Biosciences in the last 5 years

  • Overview

  • Trends

Lowest (-17.41x)

December 31, 2025

Today (-17.41x)

December 31, 2025

Industry (-13.50x)

December 31, 2025

Highest (-2.43x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -17.41x

Cogent Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cogent Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$6.0B318.72%-16.150.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.2B170.45%31.9286.04%NA
BUY$55.1B-63.37%-7.98-12.57%NA
BUY$85.8B17.94%19.984.86%0.44%

Stock Returns calculator for Cogent Biosciences Stock including INR - Dollar returns

The Cogent Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Cogent Biosciences investment value today

Current value as on today

₹3,13,279

Returns

₹2,13,279

(+213.28%)

Returns from Cogent Biosciences Stock

₹1,89,735 (+189.74%)

Dollar Impact

₹23,544 (+23.54%)

Analyst Recommendation on Cogent Biosciences Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.88888888888889% of analysts recommend a 'BUY' rating for Cogent Biosciences. Average target price of $55.82

Cogent Biosciences Share Price Target

Get share price movements and forecasts by analysts on Cogent Biosciences.

What analysts predicted

37.3%UPSIDE

Target Price

$55.82

Current Price

$35

Analyzed by

9 Analysts

Target

$55.82

Cogent Biosciences target price $55.82, a slight upside of 37.3% compared to current price of $35. According to 9 analysts rating.

Indian Investors' Interest in Cogent Biosciences Stock

Search interest for Cogent Biosciences Stock has increased by 49% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:49% versus previous 30 day period

Cogent Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-1
-
-1
-1
-
Operating Income
-62
-64
-75
-73
-74
-75
-83
-99
-103
-102
EBITDA
-57
-57
-69
-66
-70
-72
-78
-104
-94
-94
Interest Expense
-
-
-
-
-
0
1
1
1
1
Depreciation
1
1
1
1
1
1
0
1
1
0
Income Before Tax
-58
-58
-70
-67
-71
-73
-80
-102
-97
-96
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-58
-58
-70
-67
-71
-73
-80
-102
-97
-96
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cogent Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
8
9
22
7
-
-
-
-
-
Gross Profit
8
9
22
-17
-
-
-
-
-4
Operating Income
-26
-36
-32
-82
-75
-147
-208
-275
-333
EBITDA
-24
-34
-30
-34
-70
-130
-188
-251
-321
Interest Expense
-
-
-
-
-
3
-
-
3
Depreciation
1
1
1
0
1
5
3
4
4
Income Before Tax
-25
-34
-31
-74
-72
-140
-192
-255
-328
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-25
-34
-30
-74
-72
-140
-192
-255
-328
Net Profit Margin
100.00%
100.00%
99.81%
-227.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cogent Biosciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-58
-58
-70
-67
-71
-73
-80
-102
-97
-96
Operating Cash Flow
-52
-42
-51
-60
-66
-54
-64
-79
-86
-77
Investing Cash Flow
1
-84
60
61
69
8
-155
-322
-36
14
Financing Cash Flow
214
0
0
0
24
47
217
588
52
2
Change in Cash
162
-127
8
1
27
1
-2
186
-70
-60

Cogent Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-25
-34
-31
-74
-72
-140
-192
-255
-328
Operating Cash Flow
-25
-32
-41
-35
-58
-118
-153
-207
-264
Investing Cash Flow
13
-10
23
8
-1
-124
-97
38
-399
Financing Cash Flow
0
70
0
232
37
163
163
214
878
Change in Cash
-13
27
-18
204
-22
-79
-87
44
214

Mutual Funds that own Cogent Biosciences Stock

Check out the Mutual Funds with significant holdings in Cogent Biosciences.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
7.168324%
12438834
Fidelity Securities Fund
3.872298%
6719406
Fidelity Select Portfolios
2.450018%
4251394
Fidelity Advisor Series VII
1.610614%
2794818
Fidelity Concord Street Trust
1.35832%
2357025

Global Institutional Holdings in Cogent Biosciences

Funds
Holdings
Vanguard
8.57%
iShares
4.47%
Peter Harwin
3.17%
James E. Flynn
2.88%
SPDR
2.31%

Cogent Biosciences News & Key Events

  • img

    Today's Timeline - 10 August

    Mon, 05:30 PM

    -

    Cogent Biosciences reports Q2 loss of $96.4 million, with cash reserves of $792.3 million as of June 30, 2026.

    Tue, 04:38 AM

    -

    Cogent Biosciences announces $400 million ATM offering to raise capital, potentially diluting existing shareholders.

Insights on Cogent Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, COGT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, COGT stock has moved up by 187.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 285.8%

About Cogent Biosciences

Cogent Biosciences, Inc., a clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company also develops CGT4859, a reversible and selective fibroblast growth factor receptor 2 inhibitor in Phase 1 trial for patients with documented FGFR mutations, including advanced cholangiocarcinoma; CGT4255, a novel ErbB2 mutant program, which is focused on actionable and underserved mutations in a solid tumor systemic and CNS involved indications; and CGT6297, a Novel PI3Ka mutant-selective inhibitor. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts.
OrganisationCogent Biosciences
Headquarters275 Wyman Street, Waltham, MA, United States, 02451
IndustryBiotechnology
CEOMr. Andrew R. Robbins M.B.A.
E-voting on sharesClick here to vote

Key Management of Cogent Biosciences

Name

Title

Mr. Abb Hayden

Senior Vice President of Sales

Dr. John Edward Robinson Ph.D.

Chief Scientific Officer

Dr. Jessica Sachs M.D.

Chief Medical Officer

Mr. Cole Pinnow

Chief Commercial Officer

Mr. Brad Barnett

Chief Technology Officer

Mr. Evan D. Kearns J.D.

Chief Legal Officer & Corporate Secretary

Mr. Andrew R. Robbins M.B.A.

President, CEO & Director

Mr. John L. Green C.A., CPA

CFO & Principal Accounting Officer

Ms. Christi Waarich

Senior Director of Investor Relations

Ms. Erin Schellhammer

Chief People Officer

FAQs

What is Cogent Biosciences share price today?

Cogent Biosciences share price today is $35.00 as on at the close of the market. Cogent Biosciences share today touched a day high of $35.20 and a low of $34.12.

What is the 52 week high and 52 week low for Cogent Biosciences share?

Cogent Biosciences share touched a 52 week high of $43.73 on and a 52 week low of $11.60 on . Cogent Biosciences stock price today i.e. is closed at $35.00,which is 19.96% down from its 52 week high and 201.72% up from its 52 week low.

What is Cogent Biosciences's market capitalisation today?

Cogent Biosciences market capitalisation is $0.01T as on .

How to invest in Cogent Biosciences Stock (COGT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cogent Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cogent Biosciences Shares that will get you 0.0429 shares as per Cogent Biosciences share price of $35.00 per share as on September 1, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cogent Biosciences Stock (COGT) from India?

Indian investors can start investing in Cogent Biosciences (COGT) shares with as little as ₹95.152 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.52 in Cogent Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Cogent Biosciences share’s latest price of $35.00 as on September 1, 2026 at 1:29 am IST, you will get 0.2857 shares of Cogent Biosciences. Learn more about fractional shares .

What are the returns that Cogent Biosciences has given to Indian investors in the last 5 years?

Cogent Biosciences stock has given 318.72% share price returns and 30.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?